Why the study?
Myocardial hypertrophy encompasses a broad spectrum of pathologies with varying prognoses, warranting illustration of the differential diagnosis in neonates and infants through transient forms.
Maternal use of NSAIDs like Nimesulide in the third trimester of an unrecognized pregnancy can cause premature closure of the fetal ductus arteriosus, leading to severe but reversible neonatal myocardial hypertrophy.
Answers are grounded in this paper and cite their sources.
Prompts caution on late-pregnancy Nimesulide; single case report leaves open causality and generalizability.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Burešová et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: